| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/25/1999 | CA2298855A1 Interleukin-18 binding proteins, their preparation and use |
| 02/25/1999 | CA2241430A1 Novel murb |
| 02/25/1999 | CA2241403A1 Murb |
| 02/25/1999 | CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2241390A1 Pigrl-1, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2239260A1 Human disintegrin metalloprotease related to drosophila kuz gene |
| 02/24/1999 | EP0897989A2 Vehicle for delivery of particles to a sample |
| 02/24/1999 | EP0897987A2 Secretion of human protein linked to gamma interferon signal peptide |
| 02/24/1999 | EP0897986A2 Aspartic proteinase 5 (ASP5) |
| 02/24/1999 | EP0897981A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897426A1 Matrix metalloprotease |
| 02/24/1999 | EP0897424A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 02/24/1999 | EP0897390A1 Human tumor necrosis factor delta and epsilon |
| 02/24/1999 | CN1209068A Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
| 02/24/1999 | CN1208655A Research of human body's biotic science, and definiting human brain's main gene position |
| 02/23/1999 | US5874567 Therapeutic oligonucleotides targeting the human MDR1 and MRP genes |
| 02/23/1999 | US5874566 Il-15 triplex oligonucleotides |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874539 Antibodies to nuclear matrix proteins |
| 02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 02/23/1999 | US5874415 Enhancer sequence for modulating expression in epithelial cells |
| 02/23/1999 | US5874400 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874277 Proteins, their production and use |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874246 Transcription repressor |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874244 Human NADH dehydrogenase subunits and DNA thereof |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874099 Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/21/1999 | CA2241428A1 Asp5 |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999007893A1 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23 |
| 02/18/1999 | WO1999007871A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 02/18/1999 | WO1999007868A1 Immunologically privileged cells and uses thereof |
| 02/18/1999 | WO1999007860A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
| 02/18/1999 | WO1999007840A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | WO1999007832A1 Kcnq potassium channels and methods of modulating same |
| 02/18/1999 | WO1999007741A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | WO1999007723A1 Nucleic acid uptake and release vehicle |
| 02/18/1999 | WO1999007408A1 Protein factor associated with a neuro-degenerative or autoimmune and/or inflammatory disease |
| 02/18/1999 | WO1999007405A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF αvβ6 |
| 02/18/1999 | WO1999007394A1 Use of herpes vectors for tumor therapy |
| 02/18/1999 | WO1998051279A3 Method of making microencapsulated dna for vaccination and gene therapy |
| 02/18/1999 | WO1998049290A3 Syndecan interacting proteins and the use thereof |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | DE19735593A1 New Baculovirus vector for gene therapy |
| 02/18/1999 | CA2301198A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 02/18/1999 | CA2300985A1 Kcnq potassium channels and methods of modulating same |
| 02/18/1999 | CA2300977A1 Neutral sphingomyelinase |
| 02/18/1999 | CA2299630A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298840A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | CA2298451A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6 |
| 02/18/1999 | CA2296598A1 Isolation of a novel senescence-factor gene, p23 |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2267066A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0897007A2 MraY transferase |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896621A2 Cftr gene regulator |
| 02/17/1999 | EP0896620A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 02/17/1999 | EP0896614A1 Human endometrial specific steroid-binding factor i, ii and iii |
| 02/17/1999 | EP0896543A1 Drug for the treatment of tumours |
| 02/17/1999 | CN1208438A Transport proteins and their uses |
| 02/16/1999 | US5872242 Antisense oligonucleotide inhibition of ras |
| 02/16/1999 | US5872232 2'-O-modified oligonucleotides |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872154 Method of reducing an immune response to a recombinant adenovirus |
| 02/16/1999 | US5872107 Anticarcinogenic agents capture therapy for tumors |
| 02/16/1999 | US5872106 Antimessenger oligonucleotide against urokinase receptor |
| 02/16/1999 | US5872094 Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface |
| 02/16/1999 | US5872007 CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer |
| 02/16/1999 | US5872005 Packaging cell lines for adeno-associated viral vectors |
| 02/16/1999 | US5871986 Use of a baculovirus to express and exogenous gene in a mammalian cell |
| 02/16/1999 | US5871982 Hybrid vectors and genes |
| 02/16/1999 | US5871967 Cloning of a novel G-Protein coupled 7TM receptor |
| 02/16/1999 | US5871963 Nucleotide sequences |
| 02/16/1999 | US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
| 02/16/1999 | US5871931 Methods for detecting mammalian tub protein and RNA |
| 02/16/1999 | US5871767 Implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete biologically active material dispersed in biocompatible matrix, surrounded by biocompatible external jacket |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | US5871726 Tissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigen |
| 02/16/1999 | US5871723 CXC chemokines as regulators of angiogenesis |
| 02/16/1999 | US5871464 Administration of gene therapy to target cells and tissues |